MorphoSys AG (NASDAQ:MOR) and INSYS Therapeutics Inc. (NASDAQ:INSY), both competing one another are Biotechnology companies. We will compare their institutional ownership, profitability, risk, analyst recommendations, dividends, earnings and valuation.
In table 1 we can see MorphoSys AG and INSYS Therapeutics Inc.’s top-line revenue, earnings per share (EPS) and valuation.
Table 2 shows us the return on assets, net margins and return on equity of both businesses.
Ratings and Recommendations for MorphoSys AG and INSYS Therapeutics Inc. can be find in next table.
On the other hand, INSYS Therapeutics Inc.’s potential upside is 87.20% and its consensus target price is $7.75.
Institutional Insider Ownership
The shares of both MorphoSys AG and INSYS Therapeutics Inc. are owned by institutional investors at 7.3% and 18.9% respectively. Insiders Comparatively, held 63.83% of INSYS Therapeutics Inc. shares.
In this table